News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Jacobs Engineering Group Inc. Receives Medical Research Council Contract


7/15/2008 11:26:47 AM

PASADENA, Calif., July 15 /PRNewswire-FirstCall/ -- Jacobs Engineering Group Inc. announced today that it received a contract from the Medical Research Council to serve as Client Technical Advisor for its new Laboratory of Molecular Biology.

Officials did not disclose the contract value.

The 30,000-square-meter, state-of-the-art facility will be constructed on a site adjacent to Addenbrookes Hospital in Cambridge, U.K.

As Client Technical Advisor, Jacobs will provide a wide range of advisory and monitoring services related to the design and construction of the highly serviced building. Core services include architecture, building engineering services, and structural and civil engineering. Specialist services include laboratory design and commissioning, facade engineering, fire protection engineering, landscape design, and IT systems.

In making the announcement, Jacobs Group Vice President Allyn Taylor stated, "This contract award further strengthens our relationship with the Medical Research Council and we look forward to providing them with a diverse range of quality services."

Jacobs, with over 55,000 employees and revenues exceeding $9.0 billion, provides technical, professional, and construction services globally.

Any statements made in this release that are not based on historical fact are forward-looking statements. Although such statements are based on management's current estimates and expectations, and currently available competitive, financial, and economic data, forward-looking statements are inherently uncertain. We, therefore, caution the reader that there are a variety of factors that could cause business conditions and results to differ materially from what is contained in our forward-looking statements. For a description of some of the factors which may occur that could cause actual results to differ from our forward-looking statements please refer to our 2007 Form 10-K, and in particular the discussions contained under Items 1 - Business, 1A - Risk Factors, 3 - Legal Proceedings, and 7 - Management's Discussion and Analysis of Financial Condition and Results of Operations. We also caution the readers of this release that we do not undertake to update any forward-looking statements made herein.



CONTACT: Michelle Jones of Jacobs Engineering Group Inc., +1-626-578-6968

Web site: http://www.jacobs.com/


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES